Drugs A - Z

leflunomide Images

Generic Name: leflunomide

Brand Names: Arava, Aubagio

There is an FDA Alert for this drug. Click here to view it.

  • Contraindicated in pregnant women and women of childbearing potential who are not using a reliable form of contraception. (See Fetal/Neonatal Morbidity and Mortality and also see Contraindications under Cautions.)
  • Pregnancy must be excluded prior to initiation of therapy.
  • Pregnancy must be avoided while the woman is receiving leflunomide and prior to completion of the drug elimination procedure following discontinuance of the drug. (See Drug Elimination Procedures Following Leflunomide Discontinuance under Dosage and Administration.)

  • Severe liver injury, including fatal liver failure, reported.
  • Do not use in patients with preexisting liver disease or baseline ALT >2 times ULN; use with caution in patients receiving other potentially hepatotoxic drugs. (See Hepatic Effects under Cautions.)
  • Regular monitoring of ALT during therapy required; ALT >3 times ULN warrants interruption of therapy while cause is investigated. (See Hepatic Effects under Cautions.)

The Healthline Site, its content, such as text, graphics, images, search results, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.